ArticleTheranostics2021
PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
Jianfeng Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papercites it
ArticleTheranostics2021
Jianfeng Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.